
MOTS-c
Mitochondrial-derived peptide studied in AMPK and metabolic homeostasis research.
- Purity:
- ≥99% HPLC
- Sizes available:
- 10 mg – 20 mg
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
Also known as: LY3437943, Reta, triple agonist GLP-1/GIP/glucagon
Retatrutide is a synthetic triple receptor agonist studied for its simultaneous activity at the GLP-1, GIP and glucagon receptors. In published preclinical and clinical literature it is investigated in the context of energy balance, insulin sensitivity and satiety signalling pathways. Supplied as lyophilised powder for reconstitution in a laboratory setting.
| Property | Specification |
|---|---|
| Classification | Triple GLP-1 / GIP / glucagon receptor agonist |
| Also known as | LY3437943, Reta, triple agonist GLP-1/GIP/glucagon |
| Purity | ≥99% HPLC |
| Vial sizes available | 5 mg, 10 mg, 20 mg |
| Intended use | Supplied after physician review — not an approved medicine |
| Physical form | Lyophilised powder |
| Storage | -20 °C, protected from light |
| Reconstitution | Bacteriostatic water (quoted separately) |
| Testing | HPLC + mass spectrometry, per batch |
| Dispatch | Insulated cold-chain, tracked, from Argentina or the United States |
The third-party analysis behind this compound, published as the laboratory issued it — their letterhead, their report number, their key.
Open the full certificateVerify at the labChecked with this key on Janoshik Analytical's own verification page: BHNAGIAXZZ7U
Open Janoshik Analytical's verification pageEach report covers the batch submitted for it and no other. It is evidence about that material rather than a guarantee about every vial ever shipped, which is why these are dated, numbered and published one at a time instead of summarised into a badge.
Each report as a PDF, the whole page exactly as the laboratory issued it. For a purchasing file, a colleague, or a batch record.
Retatrutide99.893%
Report #136921 · Janoshik Analytical · PDF
The CoA for the specific batch you would receive is reviewed during your consultation and ships with the material.
Request this batch CoAFrom that lot's certificate of analysis, not from what the supplier asserts. The certificate names the laboratory that took the measurement, the date, the task number, the method and the purity found. PeptoClinic publishes the full reports uncropped, exactly as the laboratory printed them.
Only after a physician has reviewed your intake, and only as the guidance issued with your order sets out. None of these compounds is approved by the FDA or ANMAT for that use — which is precisely why the review exists, and why no protocol is published here for anyone to apply on their own.
It is the report an analytical laboratory issues on a specific sample. Four things are worth checking: which compound it claims to have measured, by what method (HPLC for purity, mass spectrometry for identity), what figure it found, and whether the task number can be verified against the laboratory. A certificate with no verifiable task number is a picture.
Because there is no single price. Cost turns on quantity, vial size, the documentation the programme needs and the dispatch route. Each compound is quoted in writing after a free, no-obligation technical consultation, normally within one business day.
Compounds on this site are supplied after an intake that a physician reviews one by one. None of them has been evaluated or approved by the FDA, ANMAT or any equivalent authority for the use it is requested for, and nothing on this page is a recommendation to start one on your own judgement. Whether a compound suits a given person is the reviewing physician's decision.
Compliance →
Triple-agonist metabolic research peptide targeting GLP-1, GIP and glucagon receptors.
No prices are published on this site. Every compound is quoted through a consultation.
Consult about RetatrutideNo payment. No account. No obligation. One business day response.
Request the Certificate of Analysis (CoA)
Mitochondrial-derived peptide studied in AMPK and metabolic homeostasis research.

Growth hormone-releasing hormone analogue used in endocrine signalling research.

Copper-binding tripeptide studied in extracellular matrix and dermal research models.